- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03281668
Feasibility of High Intensity Interval Training in Knee Osteoarthritis
November 4, 2019 updated by: University of North Carolina, Chapel Hill
The focus of this pilot study is to evaluate the feasibility of utilizing an evidenced-based high intensity interval training program (HIIT) to improve physical function in patients with knee osteoarthritis (OA).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All participants will be assigned to the single-arm of the study in which all participants will receive 12 weeks of HIIT, delivered twice per week.
The primary outcome will examine the feasibility and acceptability of the 12 week HIIT program in patients with knee OA symptoms ranging from mild to severe.
The investigators will determine adherence to and tolerability of HIIT, acceptability, and recruitment and retention rates during the 12 week program.
Additional outcomes will include physical function, knee OA symptomatic burden (pain), static standing balance, isometric knee extensor and flexor strength, cardiorespiratory fitness, and body composition.
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- between the ages of 40 and 75 years old
- body mass index of 18.5-50 kg/m²
- exhibits symptomatic knee OA, defined as a diagnosis of knee OA, as identified from University of North Carolina electronic medical records, and current knee symptoms in at least one knee, having a minimum score of 6 out of 20 on the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) pain subscale.
Exclusion Criteria:
- individuals diagnosed with a cardiovascular condition restricting exercise
- individuals currently meeting Department of Health and Human Services Guidelines for physical activity (≥ 150 minutes per week
- individuals currently doing HIIT
- individuals currently participating in physical therapy for knee OA
- individuals currently participating in another OA intervention study
- received a corticosteroid or hyaluronic acid intra-articular injection in the knee during the previous 3 weeks or scheduled for during the intervention
- diagnosis of gout in the knee
- diagnosis of rheumatoid arthritis
- diagnosis of fibromyalgia
- other systemic rheumatic disease
- severe dementia or other memory loss
- active diagnosis of psychosis or uncontrolled substance abuse disorder
- hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months
- total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament (ACL) tear in the past 6 months
- on a waiting list for total joint replacement
- severely impaired hearing or speech
- pregnant or planning to become pregnant while enrolled in the study
- inability to speak English
- serious or terminal illness as indicated by referral to hospice or palliative care
- nursing home residence
- inability to ride a stationary bike
- any other health problems that would prohibit safe participation in the study
- EKG results EKG suggesting the individual would not be able to safely participate in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Intervention consists of High Intensity Interval Training (HIIT) session which is af 3-5 minute warm up, followed by 10 repetitions of 1 minute bouts at individualized training intensity with 1 minute rest periods.
|
Each training session for High Intensity Interval Training will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of Potential Participants Screened for the Study Who Are Enrolled
Time Frame: Baseline
|
Number of participants screened and enrolled divided by the total number of participants screened
|
Baseline
|
Percentage of Enrolled Participants Retained at the End of the Study
Time Frame: Study completion (12 weeks)
|
Number of participants who completed the study (baseline through 12 week assessments) divided by the total number of enrolled participants with baseline assessments
|
Study completion (12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average Number of Training Sessions Completed Per Week
Time Frame: Weekly measures for 12 consecutive weeks
|
Up to 2 training sessions were possible each week over the 12 week intervention
|
Weekly measures for 12 consecutive weeks
|
Total Number of Training Sessions Completed
Time Frame: 12 weeks
|
Total number of training sessions completed out of up to 24 sessions (2 per week over 12 weeks)
|
12 weeks
|
Total Number of Training Weeks Completed
Time Frame: 12 weeks
|
Total number of training weeks (up to 12 weeks possible)
|
12 weeks
|
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score From Baseline to 12 Weeks
Time Frame: Baseline,12 weeks
|
The WOMAC, a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items), will be used to measure overall symptomatic burden of knee osteoarthritis (OA).
Each item is scored from 0-4 (none, slight, moderate, severe, and extreme).
Items are added to calculate a total WOMAC score ranging from 0 (no problems) to 96 (extreme problems).
A higher score means a worse outcome.
|
Baseline,12 weeks
|
Change in WOMAC Pain Subscale From Baseline to 12 Weeks
Time Frame: Baseline,12 weeks
|
The WOMAC pain subscale contains 5 items about knee pain.
Each item is scored from 0-4 (none, slight, moderate, severe, and extreme).
Items are added to calculate a WOMAC pain score ranging from 0 (no pain) to 20 (extreme pain).
A higher score means more severe pain.
|
Baseline,12 weeks
|
Change in WOMAC Function Subscale From Baseline to 12 Weeks
Time Frame: Baseline, 12 weeks
|
The WOMAC function subscale contains 17 items about knee function during daily activities.
Each item is scored from 0-4 (none, slight, moderate, severe, and extreme).
Items are added to calculate a WOMAC pain score ranging from 0 (no problems with function) to 68 (extreme problems with function).
A higher score means worse function.
|
Baseline, 12 weeks
|
Change in 20m Fast Paced Walk Test
Time Frame: Baseline, 12 weeks
|
Measure of the ability to walk quickly over short distances.
Participants walk at fast pace that is timed over 2 x 10m.
|
Baseline, 12 weeks
|
Change in Number of Chair Stand Repetitions Completed
Time Frame: Baseline, 12 weeks
|
Number of chair stand repetitions completed in 30 seconds
|
Baseline, 12 weeks
|
Change in Stair Climb Test
Time Frame: Baseline, 12 weeks
|
Time in seconds to ascend and descend a flight of stairs
|
Baseline, 12 weeks
|
Change in Timed Up and Go
Time Frame: Baseline, 12 weeks
|
Time in seconds to rise from a chair, walk 3 m, turn, walk back to chair, and sit down
|
Baseline, 12 weeks
|
Change in Feet Together Stand
Time Frame: Baseline, 12 weeks
|
Feet together stand for up to 10 seconds without assistive device
|
Baseline, 12 weeks
|
Change in Semi-tandem Stand
Time Frame: Baseline, 12 weeks
|
Heel of one foot placed to the side of the big toe of the other foot, for up to 10 seconds
|
Baseline, 12 weeks
|
Change in Tandem Stand
Time Frame: Baseline, 12 weeks
|
One foot in front of the other, heel touching toe, for up to 10 seconds
|
Baseline, 12 weeks
|
Change in One Leg Stand
Time Frame: Baseline, 12 weeks
|
One leg stand for up to 30 seconds
|
Baseline, 12 weeks
|
Change in Cardiorespiratory Fitness
Time Frame: Baseline, 12 weeks
|
Measure by peak oxygen consumption (VO2peak),to identify fitness level and evaluate cardiovascular effects.
Test will establish individual training intensity.
|
Baseline, 12 weeks
|
Change in Whole Body Fat Mass
Time Frame: Baseline, 12 weeks
|
fat mass in kilograms, measured with dual energy x-ray absorptiometry (DXA)
|
Baseline, 12 weeks
|
Change in Lean Body Mass
Time Frame: Baseline, 12 weeks
|
lean body mass in kilograms, measured with DXA
|
Baseline, 12 weeks
|
Change in Visceral Fat
Time Frame: Baseline, 12 weeks
|
visceral fat in kilograms, measured with DXA
|
Baseline, 12 weeks
|
Change in Knee Strength
Time Frame: Baseline, 12 weeks
|
Humac isokinetic dynamometer to measure isokinetic power and isometric strength of knee flexors extensors
|
Baseline, 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Yvonne Golightly, PT, PhD, University of North Carolina, Chapel Hill
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2017
Primary Completion (Actual)
November 9, 2018
Study Completion (Actual)
November 9, 2018
Study Registration Dates
First Submitted
August 31, 2017
First Submitted That Met QC Criteria
September 11, 2017
First Posted (Actual)
September 13, 2017
Study Record Updates
Last Update Posted (Actual)
November 22, 2019
Last Update Submitted That Met QC Criteria
November 4, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-2996
- 1R21HD088852-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on High intensity interval training (HIIT)
-
Université de SherbrookeRecruiting
-
Mayo ClinicRecruitingCardiac RehabilitationUnited States
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
Chang Gung Memorial HospitalCompletedHeart Failure | Morality | Remodeling, VentricularTaiwan
-
Brock UniversityCompletedCardiovascular Diseases | Metabolic SyndromeCanada
-
McMaster UniversityUnknown
-
Amsterdam UMC, location VUmcRecruitingExercise | Brain Tumor, PrimaryNetherlands
-
VA Office of Research and DevelopmentAtlanta VA Medical CenterNot yet recruitingStroke | Stroke Rehabilitation | Walking, Difficulty | Lower Extremity Weakness, SpasticUnited States
-
Karolinska InstitutetRecruitingOverweight | Type 1 DiabetesSweden
-
The University of Texas Health Science Center at...WithdrawnMetastatic Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma | Castrate Resistant Prostate CancerUnited States